 |
Previous Article | Next Article 
The Journal of Neuroscience, March 1, 2000, 20(5):2064-2071
Hypothalamic-Pituitary-Adrenal Dysfunction in
Apoe / Mice: Possible Role in Behavioral and
Metabolic Alterations
Jacob
Raber1, 2,
Susan
F.
Akana3,
Seema
Bhatnagar3,
Mary F.
Dallman3,
Derek
Wong1, and
Lennart
Mucke1, 2
1 Gladstone Institute of Neurological Disease and
Departments of 2 Neurology and 3 Physiology,
University of California, San Francisco, California 94141-9100
Several neurological diseases are frequently accompanied by
dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. The
HPA axis regulates the secretion of glucocorticoids (GCs), which play
important roles in diverse brain functions, including cognition,
emotion, and feeding. Under physiological conditions, GCs are adaptive
and beneficial; however, prolonged elevations in GC levels may
contribute to neurodegeneration and brain dysfunction. In the current
study, we demonstrate that apolipoprotein E (apoE) deficiency results
in age-dependent dysregulation of the HPA axis through a mechanism
affecting primarily the adrenal gland.
Apoe / mice, which develop
neurodegenerative alterations as they age, had an age-dependent
increase in basal adrenal corticosterone content and abnormally
increased plasma corticosterone levels after restraint stress, whereas
their plasma and pituitary adrenocorticotropin levels were either
unchanged or lower than those in controls. HPA axis dysregulation was
associated with behavioral and metabolic alterations. When anxiety
levels were assessed in the elevated plus maze,
Apoe / mice showed more anxiety
than wild-type controls. Apoe /
mice also showed reduced activity in the open field. Finally, Apoe / mice showed age-dependent
increases in food and water intake, stomach and body weights, and
decreases in brown and white adipose tissues. These results support a
key role for apoE in the tonic inhibition of steroidogenesis and HPA
axis activity and have important implications for the behavioral
analysis of Apoe / mice.
Key words:
apoE; pituitary; adrenal gland; ACTH; corticosterone; HPA
axis; anxiety; open field activity; metabolism
Copyright © 2000 Society for Neuroscience 0270-6474/00/2052064-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Elahi, F. R. Cagampang, F. W. Anthony, N. Curzen, S. K. Ohri, and M. A. Hanson
Statin Treatment in Hypercholesterolemic Pregnant Mice Reduces Cardiovascular Risk Factors in Their Offspring
Hypertension,
April 1, 2008;
51(4):
939 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Esposito, J. Raber, L. Kekonius, F. Yan, G.-Q. Yu, N. Bien-Ly, J. Puolivali, K. Scearce-Levie, E. Masliah, and L. Mucke
Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.
J. Neurosci.,
May 10, 2006;
26(19):
5167 - 5179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chin, J. J. Palop, J. Puolivali, C. Massaro, N. Bien-Ly, H. Gerstein, K. Scearce-Levie, E. Masliah, and L. Mucke
Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci.,
October 19, 2005;
25(42):
9694 - 9703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Caselli, E. M. Reiman, J. G. Hentz, D. Osborne, and G. E. Alexander
A Distinctive Interaction Between Chronic Anxiety and Problem Solving in Asymptomatic APOE e4 Homozygotes
J Neuropsychiatry Clin Neurosci,
August 1, 2004;
16(3):
320 - 329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Harris, W. J. Brecht, Q. Xu, I. Tesseur, L. Kekonius, T. Wyss-Coray, J. D. Fish, E. Masliah, P. C. Hopkins, K. Scearce-Levie, et al.
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice
PNAS,
September 16, 2003;
100(19):
10966 - 10971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Thorngate, P. A. Strockbine, S. K. Erickson, and D. L. Williams
Altered adrenal gland cholesterol metabolism in the apoE-deficient mouse
J. Lipid Res.,
November 1, 2002;
43(11):
1920 - 1926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Raber, G. Bongers, A. LeFevour, M. Buttini, and L. Mucke
Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits
J. Neurosci.,
June 15, 2002;
22(12):
5204 - 5209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Peskind, C. W. Wilkinson, E. C. Petrie, G. D. Schellenberg, and M. A. Raskind
Increased CSF cortisol in AD is a function of APOE genotype
Neurology,
April 24, 2001;
56(8):
1094 - 1098.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|